TickerFacts.

Embecta Corp. (EMBC): Revenue

Annual figures by period end, from SEC filings.

$1.08B
Year ended 2025-09-30
$1.02B
Trailing 12 months to 2026-06-30
-1.5%
3-year compound annual growth
-0.1%
5-year compound annual growth
$1.17B2020-09-30: $1.09B2021-09-30: $1.17B2022-09-30: $1.13B2023-09-30: $1.12B2024-09-30: $1.12B2025-09-30: $1.08B$1.08B
2020-09-30 Revenue (USD) 2025-09-30
Period endedRevenueChange YoYSource filing
2025-09-30$1.08B-3.8%2025-11-25, From 2024-10-01
2024-09-30$1.12B+0.2%2025-11-25, From 2023-10-01
2023-09-30$1.12B-0.8%2025-11-25, From 2022-10-01
2022-09-30$1.13B-3.1%2024-12-11, From 2021-10-01
2021-09-30$1.17B+7.4%2023-11-29, From 2020-10-01
2020-09-30$1.09Bn/a2022-12-22, From 2019-10-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Embecta Corp. (EMBC)2025-09-30$1.08B-3.8%
Tandem Diabetes Care Inc (TNDM)2025-12-31$1.01B+7.9%
Inspire Medical Systems, Inc. (INSP)2025-12-31$911.98M+13.6%
Haemonetics Corp (HAE)2026-03-28$1.33B-2.0%
Penumbra Inc (PEN)2025-12-31$1.40B+17.5%
Orthofix Medical Inc. (OFIX)2025-12-31$822.31M+2.9%
Merit Medical Systems Inc (MMSI)2025-12-31$1.52B+11.8%
Alphatec Holdings, Inc. (ATEC)2025-12-31$764.15M+25.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$747.14M+26.2%

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗